Empowering appropriate antimicrobial use with rapid diagnostics.

OUR MISSION

The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner with rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.

1.0_TTT_dividerbar_440

LATEST NEWS

Alere Hosts Event Responding to Challenge of Antimicrobial Resistance (AMR) in Ireland

Mar. 08, 2017: The high-level, multi-stakeholder roundtable event explored the uptake of antimicrobial… Read More

United Nations Establishes Interagency Coordination Group on Antimicrobial Resistance

On 21 September 2016, world leaders gathered at the United Nations General Assembly in New York… Read More

WHO today published its first ever list of bacteria that pose the greatest threat to human health

On February 27th WHO published its first ever list of antibiotic-resistant "priority pathogens"… Read More

Antibiotic resistance rising in Europe

A new report on antimicrobial resistance from the European Centre for Disease Prevention and Control… Read More

First recorded cases of frontline malaria drug failing to treat UK patients

For the first time, cases of resistance to anti-malaria drugs have been reported in the UK… Read More

RAPID DIAGNOSTIC TESTING

A comprehensive set of diagnotic information, empowering a shift  in prescribing behavior away from the over-use of antibiotics.

1.0_TTT_dividerbar_440
Contact

WANT TO LEARN MORE?

Register for our monthly Test Target Treat e-newsletter alerting you to new educational tools.